Media Archive 2007

NAPC 2007 Conference

 

 

 

 

 

ABPI
12 Whitehall
London SW1A 2DY

The  ABPI  brings  together  more  than  100 companies in Britain producing branded   and   generic  prescription  medicines  and  others  involved  in pharmaceutical  R&D  and  with  an  interest in the pharmaceutical industry operating in Britain. Its member companies supply around 80 per cent of the medicines prescribed through the NHS.

The  Association maintains close and regular contact with political opinion leaders  and  Government bodies and agencies, at both national and European levels.

For  more  information  please visit our website: www.abpi.org.uk or email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it / tel: 0207 930 3477.

 

AMSPAR
The Association of Medical Secretaries, Practice Managers, Administrators and Receptionists (AMSPAR) is a registered, nationally recognized awarding body and membership organization. We provide non-clinical qualifications included within the National Qualifications Framework for medical administrative and management personnel.

We aim to promote quality and coherence in the delivery of qualifications, and encourage and support standards of excellence in the pursuit of continuous professional development and lifelong learning.

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. The company’s products and services are designed to benefit people and improve their quality of life. At the same time Bayer creates value through innovation, growth and improved earning power. The Group is committed to the principles of sustainable development and acknowledges and accepts its role as a socially and ethically responsible “corporate citizen”. Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal 2006, Bayer employed 106,000 people and had sales of around €29 billion.

For more information, go to www.bayer.co.uk

Evidence-based medicine is at the heart of BMJ Clinical Evidence.  Systematic reviews summarise the current state of knowledge and uncertainty about the prevention and treatment of clinical conditions, based on thorough searches and appraisal of the literature.  Clinicians are, therefore, provided with the very latest and most relevant medical knowledge, to support treatment decisions and improve patient care.

Available in a variety of formats, BMJ Clinical Evidence enables Clinicians to access the information whenever needed and has been cited as one of the world’s most authoritative medical resources.

Clinicalevidence.bmj.com for more information.


Bristol-Myers Squibb Pharmaceuticals Limited

Uxbridge Business Park
Sanderson Road
Uxbridge
Middlesex
UB8 1DH

Main Switchboard: 01895 523000

Bristol-Myers Squibb (Bristol-Myers Squibb) is a global pharmaceutical and related healthcare products company whose mission is to extend and enhance human life.  Bristol-Myers Squibb’s primary focus is on the medicines business involving research, development, manufacturing and supply of high-quality medicines around the world.

As one of the world’s leading pharmaceutical companies, Bristol-Myers Squibb has been a pioneer in pharmaceutical research and development for more than half a century.  Our commitment to R&D has resulted in the discovery and development of innovative medicines to fight cardiovascular disease, HIV/AIDS, cancer and mental health disorders. 

 

BUPA Commissioning

BUPA Commissioning has been set up to deliver a wide range of management services to PCT’s across England.  With the most extensive healthcare commissioning capabilities in the UK outside the NHS, BUPA has the breadth of resources to deliver a wide range of scaleable solutions to each PCT.

We currently commission care for 3 million customers in the UK.  We contract with and performance manage 1,000 hospitals in the UK, including over 80% of NHS hospitals and we have a dedicated demand management contact centre in Salford with over 100 staff.

BUPA is a provident association with no shareholders – we exist solely for the benefit of patients.

Contact: Monica Owen, BUPA Commissioning
Tel: 0845 600 3036
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.bupacommissioning.co.uk

CONNECT
Connect are a specialist primary care physiotherapy provider, delivering exclusively in primary care for over 15 years.

A diverse portfolio of services are on offer including;

- ‘PhysioLine’ offering patients a telephone appointment via self or GP referral within 48 hrs.
- Practice-based physiotherapy via self of GP referral
- Clinical Assessment & Treatment service (CATs) manned by PwSIs and physiotherapists.

Connect provide a quality assured workforce and adopt a flexible, partnership approach, working with practices, practice based commissioners and PCTs to develop improved ways of working focusing on patient need.


The Department of Health Commissioning Team

Commissioning is the means to secure the best value for local citizens. It is the process of translating aspirations and need, by specifying and procuring services for the local population, into services for users.

Developing a world class commissioning function will be crucial if health and care services are to achieve the best possible outcomes for patients and users, improve health and reduce health inequalities, whilst ensuring that resources are invested effectively and efficiently. Practice based commissioning will be central to this, as the key mechanism for engaging primary care clinicians in improving local health and social care systems.


Dr Foster Intelligence is the market-leading provider of information, analysis, training, and targeted communications to health and social care organisations. Our management information products are used to help primary and secondary care commissioners and providers deliver against targets such as reducing emergency admissions, improving mortality ratios and achieving significant cost savings. In addition, Dr Foster Intelligence helps health and social care services deliver a range of targeted communications solutions to tackle key public health issues such as obesity and smoking. 


The Expert Patients Programme (EPP) is a six week course for people with chronic or long-term health conditions. The course is delivered by trained volunteer tutors who are also living with a long term health condition. It aims to give people the confidence to take more responsibility and self-manage their health, while encouraging them to work collaboratively with health and social care professionals.  The EPP does not provide health information or treatment, nor does it address clinical needs. Course topics include healthy eating, dealing with pain and extreme tiredness, relaxation techniques and coping with feelings of depression.


Haymarket Medical Media has a deep understanding of primary care. For more than 40 years we have published the weekly GP newspaper and the monthly drug reference MIMS. Other flagship titles include the fortnightly nurse prescribing journal Independent Nurse, and our comprehensive website for the whole primary care team, healthcarerepublic.com. We recently launched the quarterly specialist journals MIMS Dermatology, MIMS Cardiovascular and MIMS Women’s Health. Meanwhile, our contract publishing division, Medical Imprint, produces more than 100 bespoke medical education projects every year. Health professionals rely on us for essential clinical and management information and all the latest career opportunities.


InHealth Diagnostic & Imaging is one of the market leaders of managed diagnostic services.  Established for over 15 years, we have over 700 contracts within the NHS, and have a proven track record of clinical governance and outstanding levels of patient care. We have 30 static and 15 mobile diagnostic units covering the widest range of diagnostic services in the UK. These include
•       MRI
•         CT
•         PET/CT
•         Plain film x-ray
•         Digital Mammography
•         Nuclear Medicine
Services (MPS)
•         Dexa Scanning
•         Cardiac Services
   Mobile cath labs
   Cardiac CT
•         Audiology Services
•         Endoscopy
•         BP monitoring
•         ECG
•         Echo Cardiography
 
We offer these services from state of the art facilities, both mobile and static and employ a highly dedicated team of clinical staff.  We also provide reporting services (where applicable) from our UK based radiology reporting team and adhere to highly stringent, self-imposed clinical protocols, with established and easy to follow patient pathways.  We are highly experienced in working with local stakeholders to develop forms and pathways appropriate to local needs.


Intouch will be demonstrating their Staywell range of Self Care Audit and Information Tools. Staywell helps patients with Long Term conditions to identify gaps in their self-care knowledge and delivers information to help educate them. Clinicians use this information as the basis of their next consultation to identify patients who are at risk of developing complications.
Main benefits:-
Improves self care through better knowledge
Reduces outpatient referrals and emergency outpatient admissions
Improves medication compliance
Supports demand management
Payback is very quick. A 40 practice PCT can save £600,000 if only one admission per practice per year is avoided.

 

LEO Pharma
LEO Pharma is among the world’s leading companies in parenteral treatment of thromboembolic disorders and topical dermatology. LEO Pharma is owned entirely by the LEO Foundation and is committed to improving patient care whilst increasing awareness and understanding within its specialist disease areas. With no shareholders, money can be reinvested into what really matters: pioneering treatment for the benefit of patients.
LEO Pharma is also committed to developing service redesign programmes, educational initiatives and service provision.

For more information about LEO Pharma’s products or educational resources, please telephone 01844 347333 or email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Napp Pharmaceuticals
Napp Pharmaceuticals is part of a worldwide association of independent pharmaceutical companies that have been developing vital new drugs for more than half a century.
Napp pioneered the creation of prolonged release drugs, particularly for the relief of severe pain. Its development of controlled-release morphine sulphate tablets (MST® Continus® tablets) was a world first, and it now produces 18 analgesics in 52 different formulations. Napp also produces a number of other medicines for the treatment of cardiovascular disease, respiratory disease and gastrointestinal problems.
The company moved to the prestigious Cambridge Science Park in the early 1980s, opening its striking UK headquarters building in 1983.
The success of its research and sales operations has seen the number of employees grow to more than 800, and Napp's facilities have expanded into three other buildings on the Science Park. 
Napp's sales have grown significantly and it is now rated 18th by size of prescription-only medicine sales among 230 companies in the UK pharmaceutical industry.


NHS Choices is a fully inclusive, online resource that provides easily
accessible information about conditions, treatments and hospitals. Hosted on www.nhs.uk NHS Choices was launched to meet the huge demand for comprehensive health information which is quality assured and with the 21st Century patient in mind.  By harnessing the power of information technology, the new service provides GPs access to a wide range of materials about common conditions and treatments. Pamphlet style guides that are written in easy to understand language can be printed off quickly and cheaply in surgeries and given to patients. Comparative clinical data is provided for 35 of the most common elective procedures which can be used
by GPs with their patients to make informed decisions about when and where they receive treatment.

"NHS Connecting for Health supports the NHS in providing better, safer care by delivering computer systems and services which improve the way patient information is stored and accessed."


Orion Diagnostica’s QuikRead® CRP is a simple test for measurement of C-reactive protein from a fingerstick blood sample. Interpreted in the light of full clinical information, the test result can aid the health care practitioner in differentiating between bacterial and viral infections and in identifying patients who need – or do not need – antibiotic treatment.

Pfizer  
Pfizer, with its UK business headquarters in Surrey and global headquarters in New York, is a research-based global pharmaceutical company. Pfizer discovers, develops, manufactures and markets leading prescription medicines for humans and animals, and many of the world's best-known consumer treatments. Every month, over two million patients in the UK are prescribed a Pfizer medicine. It is estimated that on any given day, 40 million people around the world are treated with a Pfizer medicine.

Boehringer Ingelheim
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 143 affiliates in 47 countries and almost 37,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2005, Boehringer Ingelheim posted net sales of 9.5 billion euro while spending almost one fifth of net sales in its largest business segment Prescription Medicines on research and development.

Boehringer Ingelheim and Pfizer are committed to fighting Chronic Obstructive Pulmonary Disease (COPD) together. We aim to improve recognition and management of COPD, which can make a real difference to the quality of life of patients.


Picker Institute Europe
Kings Mead House
Oxpens Road
Oxford
OX1 1RX

Tel: 01865 208100
Fax: 01865 208101
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
URL: www.pickereurope.org

 

Picker Institute Europe works with patients, professionals and policy makers to promote understanding of the patient’s perspective at all levels of healthcare policy and practice.

We undertake a unique combination of research, development and policy activities which together work to make patients’ views count.  With our public engagement services we can assist commissioners in finding out what local people think about their health and social care priorities.  We work with organisations to select and implement the methods and techniques best suited to gathering the information required.


Sapphire Primary Care Developments         

Sapphire Primary Care Developments Ltd is a specialist developer of innovative health solutions tailored to provide local facilities for the delivery of patient care.  As the development arm of Lloydspharmacy, Sapphire is committed to the provision of multifunctional space, enabling the full integration of services.  As one of the most active developers of Primary Care Centres, Sapphire can tailor its delivery to offer flexible ownership or leasing arrangements, fast track delivery, and risk free completion.  Call us on 02476 432270 or visit our web site www.sapphirepcd.co.uk

Schering-Plough
Schering-Plough is a global science-based healthcare company with leading prescription, consumer and animal health products.  Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs.  Schering-Plough’s vision is to earn the trust of the physicians, patients and customers served by its workforce of more than 32,000 people around the world. Schering-Plough UK is a country operation of Schering-Plough.
 
Schering-Plough UK has created a new specialist team to develop partnerships that are beneficial to the emerging commissioning groups within the changing NHS.  Partnership Development Managers will provide a valuable interface with key customer networks within primary care, secondary care and disease networks.

Servier Limited
Servier Limited is the British Subsidiary of the Servier Research Group, a leading French based organisation specialising in ethical pharmaceuticals. Servier is currently within the top 15 largest pharmaceutical companies in the UK.
Servier’s product portfolio in the UK focuses on the therapeutic areas of Cardiovascular disease, Diabetes and Osteoporosis. Research is ongoing in these areas and also in mental health.


THE SOLLIS PARTNERSHIP LTD
We have a thirteen year history of delivering healthcare intelligence systems to the NHS. We have a long history working in Primary Care particularly in healthcare commissioning. We provide specialist support in terms of data collection, analysis & reporting for Practice Based Commissioning (PBC).

Our intelligence systems currently provide PBC support to a large number of PCTs and GP Practices nationally. These include all PCTs and Practices across the West Midlands Strategic Health Authority (17 PCTs & 1,100 Practices).

At this conference we will be showcasing our PBC intelligence system – CLARITY.PBC. CLARITY.PBC delivers PBC intelligence for PCTs and Practices.

Tel: 01372 847 503
Mob: 07768 034542
Fax: 01372 739 014
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
 
Web:    www.sollis.co.uk

t+ Medical
t+ Medical is a private British company and provides complete monitored disease management systems for COPD, diabetes, asthma and hypertension. The t+ system harnesses the computing power of the patients own mobile phone to deliver algorithm assisted, real-time patient monitoring in a low cost, high convenience solution.
By transmitting vital signs information to a secure encrypted web site, Tele-nurses and other healthcare professionals can now evaluate long term condition patients in real time.
The t+ medical prioritisation process highlights, in just a few clicks, those patients who need assistance with the management of their condition.

 

 
 

Appointment to Lord Darzis Review Board

 

The National Association of Primary Care (NAPC) very much welcomes the appointment of Dr James Kingsland, its Chairman, to Lord Darzi’s review board.  The announcement was made by Ben Bradshaw, Minister of State for Health at NAPC’s Annual Conference, held on 17th and 18th of October 2007.  Mr Bradshaw, MP confirmed that the appointment of Dr Kingsland would significantly strengthen Lord Darzi’s board.

Dr Kingsland commented:  ‘I am delighted to be invited to be involved in the work of the review board on behalf of NAPC and its wider membership’.  ‘This is an important and key review for primary care’, he continued, ‘and it is critical that contributions are made by the innovative and forward thinking clinicians and managers, whom NAPC represents.  It will be important to strike the right balance in delivering solutions which address local problems, while avoiding reinvention of the wheel over and over again.’

 A full copy of the Minister’s speech can be downloaded from NAPC’s website at www.napc.co.uk

 
 

NAPC Conference - Minister's Speech

 

Thank you very much for inviting me to your conference. I’d like to begin by congratulating all those who have helped to make it a success.  I have been impressed by your enthusiasm and dedication to improving services for patients, particularly through your support of practice based commissioning policy and implementation.

With the recent changes in the Ministerial team and at the top of Government, it is inevitable that people ask if the Government’s commitment to practice based commissioning still stands, and if the direction of travel is the same.  I want to make it absolutely clear that practice based commissioning is here to stay.  We remain as committed as ever to successful implementation.  If anything, in the context of my colleague, Lord Darzi’s review, I would expect our commitment to become stronger and the speed of travel quicker.  Ara’s interim report was published this month and sets out a vision for an NHS which will deliver effective, higher quality services that are safe, personalised to individual needs, and equally available to all.  The report emphasises the need for practice based commissioners to use NHS funds more flexibly and to find alternatives to traditional NHS provision.  You are the people who will help us deliver this vision.

It will require better collaboration between Primary Care Trusts, GPs and other health professionals.  It is about better clinical engagement and better services for patients.  It is about a better use of Primary Care Trust resources.  We want to see GPs working with other primary care professionals.  We want to see GPs and other primary care professionals having constructive relationships with their Primary Care Trust, hospitals, social services and other local organisations.  We want to see front line clinicians leading the design and commissioning of services on behalf of their patients, with their patients. 

It will create greater flexibility for practices to innovate and design services, with more decisions being made at practice – not Primary Care Trust – level.  Those in the best position to make decisions – GPs – will be able to make those decisions.  Where practices free up resources through more effective commissioning, they will be able to reinvest at least 70% of these resources into local patient care.

As many of you  know, these are not just aspirations.  There are already plenty of practice based commissioners working successfully on the ground.  In Hartlepool, a nurse-led Community Respiratory Assessment and Management Service provides a new walk-in facility for patients.  This has reduced emergency admissions and the number of consultations required. 

In Waltham Forest, a practice based redesigned patient pathway to run a carpal tunnel service has saved £93,000 and significantly reduced waiting times.

In West Kent, GPs have redesigned the pathway and specification of a Deep Vein Thrombosis service.  Previously, patients had to wait at least two weeks for ultrasound scans while having daily injections.  By introducing immediate screening in the GP surgery, this has resulted in fewer scans and admissions for Deep Vein Thrombosis, improved the patient experience and produces yearly savings of £300,000.  These savings can go straight back into reinvestment in patient care.

And very soon I am planning a visit to Havering soon to visit Dr Deshpande, a GP with Special Interests in Urology.  What he has achieved via practice based commissioning is truly revolutionary.  Dr Deshpande persuaded his local practice based commissioning consortium to invest in technology.  A new diagnostic service for patients with suspected benign prostatic hyperplasia was set up using this technology.  Diagnostic tests are now taken in the surgery and scans are transmitted down an ISDN (Integrated Services Digital Network) line to a radiologist who looks at the scans in real time: all this while the patient is being examined.  The service has cut waiting times from at least 30 weeks to around 4 weeks.  For every 200 patients seen, the service saves £62,000.  Across a single Primary Care Trust with sixteen practices this would amount to almost £1 million.  Money that can be reinvested in more and better services for local people.

But we are under no illusion that practice based commissioning is a roaring success across the whole country yet.  We know that in some places, arrangements for practice based commissioning need improving and strengthening.  Commissioning should not be a struggle between Primary Care Trusts wanting to hold onto their commissioning role and practice based commissioners wanting to take it away from them.  Primary Care Trust commissioning should be based on supporting practice based commissioning, and practice based commissioners should be fully involved in local strategic planning, including local development plans and Local Area Agreements. 

But we know that there are still barriers to overcome.  Timely, high quality information is crucial to successful, practice based commissioning and is an area which needs further development.  We are therefore establishing a Primary Care Trust-led demonstration project in each Strategic Health Authority to focus on how Trusts and practices can make effective use of information to deliver measurable commissioning outcomes. These projects will produce models of best practice relating to the provision of information to practices and these models will then be rolled out to other Primary Care Trusts and practices.

What can you do to help make all this a success?  Well, I can only echo the advice of Hartlepool’s Professional Executive Committee Chair and practice based commissioning lead: “look at what’s going on, look carefully at data, identify problems, decide what can be done differently and then get on with it!”  We want to encourage practices to ask the Primary Care Trust for support with practice based commissioning – you must be proactive in doing this.

Commissioning is not a hierarchy going down from the Department of Health down to practice based commissioning at the lowest level.  In a decentralised NHS, it is the other way round.  NHS commissioning must be a product of all those individual meetings between the frontline clinician and his or her patient.  Lord  Darzi’s report reaffirmed the importance of service redesign being a bottom up approach, and the importance of clinicians being at the forefront of service redesign.  And we are serious about encouraging you – front line practitioners and managers – to lead the way towards effective commissioning.

Lord Darzi’s report also recommended the appointment of a primary care advisory board that will help develop future strategy on primary care.  The board will includes GPs, community nurses and other health and care professionals.  Today, I am pleased to announce that James Kingsland, your chairman, has agreed has agreed to sit on this board.  We value his personal contribution and the recommendations that he will no doubt bring to the table.

While we want to encourage you, your feedback has also been encouraging us.  The first results of a quarterly practice survey, undertaken on behalf of the Department of Health by IPSOS Mori, will be published at the end of this month.  It will show that some things are going well, and other things still require work.  Encouragingly, the response rate to the survey has been much higher than we anticipated.  Nearly 1,200 out of 2,000 practices surveyed replied: a response rate of around 60%.  This demonstrates that there is a good level of interest in practice based commissioning amongst practices and that they are keen to share their views.  And the survey also confirms that support for practice based commissioning as a policy remains strong among GPs.  The survey does highlight a number of areas where frustrations remain, and we are committed to addressing those.

Service redesign is no longer a minority sport.  The survey suggests that practices are beginning to commission new services through practice based commissioning: it shows that a third of practices have commissioned one or more new services.  So this is a very good result, considering that practice based commissioning represents a major cultural shift for both practices and Primary Care Trusts – and cultural shifts, as we all know in the health service, can be slow to take effect.

I really want to make sure that practice based commissioning continues to develop and I want to encourage all parts of the NHS to support it.   The programme of work to develop World Class Commissioning that we’ve instigated will establish practice based commissioning as the key route for effective clinical engagement.  We are developing jointly with NHS partners, including front line clinicians, a vision for World Class Commissioning, an assurance framework to hold commissioners to account, and a support & development framework to provide the tools to achieve world class status.

The most important thing is that we, together, communicate and celebrate what is positive in practice based commissioning.  I know that the Secretary of State has already met some practice based commissioners around the country and was highly impressed by their work.   He is as keen as I am to get out and see more great examples of practice based commissioning in action.

Without good and widespread practice based commissioning, we will not be able to achieve the clinician led, patient centered, high quality and value for money health care which we all believe in – and which the public expects. 

I am happy to take any questions now. (MS (H) may like to say this, or let the panel introduce the formal Q&A.)

Thank you.

 

 

 
 

Press Statement - NHS Funding

 

 
NAPC very much welcomes the outcome for the NHS of the Chancellor’s comprehensive spending review, announced yesterday, with spending set to rise to £110bn by 2010 from the current £90bn.

Dr Kingsland, Chairman of the Association commented: ‘The 4% a year rise in real terms is evidence of the government’s commitment to the NHS.  The sums involved should make a real difference to the challenges it faces and to the health of the people of this country’.

‘NAPC is pleased to see that the government is set to spend over £1billion more than previously planned’, Dr Kingsland continued ‘to fund improvements in GP care’.  ‘The use of funds to improve access to services for patients is, of course, right and proper’.  ‘However,’ he stated, ‘there are some residual concerns about the ownership and management of the proposed new health centres.  Historically, NHS managed health centres, were not a success.  NAPC will be responding shortly to these and other proposals of Lord Darzi’s’.  Dr Kingsland went on: ‘It is only right and proper that efforts should be made to ensure that the investment the government makes is well-founded and produces real time benefits to patients’.

  ***ENDS***

Dr James Kingsland, NAPC Chairman:    
Telephone Number:  07887 894124

Mike Ramsden, NAPC, CEO:                  
Telephone Number:  07946 380017

 

 About National Association of Primary Care:

The National Association of Primary Care (NAPC) is a non-political, non-profit-making organisation representing and supporting the interests of all its members, both individuals and organisations working in or with primary care.  It also offers support through associate membership to those bodies, which provide services to primary care or have other health-related interests.

 
 
<< Start < Prev 1 2 3 4 5 6 Next > End >>

Page 2 of 6